William D. Waddill, Director at Protagonist Therapeutics, Inc (PTGX), sold 12,000 shares at $87.81 ($979K) on 2025-10-10, disclosed to the SEC on 2025-10-14.
Scheduled sale ($979k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.25 | 4,000 | $277K | 28.3% |
| 2 | $87.81 | 8,000 | $702K | 71.7% |
| Total | $81.62 avg | 12,000 | $979K | 100% |
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |